:strip_icc()/i.s3.glbimg.com/v1/AUTH_59edd422c0c84a879bd37670ae4f538a/internal_photos/bs/2020/M/S/RtuURXTBybwamiZwDLAQ/115080439-fa074d24-f0d1-49b1-91fb-54d76511d213.jpg)
[ad_1]
The Indian government will not allow the export of the Oxford / AstraZeneca vaccine against Covid-19 produced in India, said on Sunday (3), the director of the Serum Institute, a manufacturer contracted to produce one billion doses of the vaccine for countries. Developing. development.
It is the same manufacturer that the Oswaldo Cruz Foundation (Fiocruz) announced on Sunday that it had closed a contract for the acquisition of doses of the vaccine. It is not yet clear how the decision could affect deliveries.
Fiocruz said in a statement that the Foreign Ministry is at the forefront of negotiations related to the importation of ready doses of vaccines from India. OR G1 contacted Itamaraty and, until the last update of this report, received no response.
Exports will halt until India’s most vulnerable population is immunized, Serum Institute president Adar Poonawalla said in an interview with the Associated Press news agency. He also said that the company was prevented from selling its doses to private organizations.
“We can only deliver (the vaccines) to the government of India at this time,” Poonawalla said.
The manufacturer’s president said in another interview with Reuters that exports could only be made after obtaining 100 million doses for the Indian government, which could delay deliveries to other countries by up to two months.
“The government of India just wants to make sure the most vulnerable people in the country get it first. I fully support and support this decision,” he said.
OR G1 contacted the Serum Institute and the Indian Embassy in Brazil and as soon as it has a response on how the restrictions may affect Brazilian imports, it will update this report.
